You are here: Industry Insights > Vect-Horus

News List

Vect-Horus enters into Collaboration and License Agreement with Ono Pharmaceutical Co., Ltd. pharmafocusasia
March 27, 2019
Vect-Horus S.A.S. (Marseille, France) announced today that Vect-Horus and Ono Pharmaceutical Co., Ltd. (Osaka, Japan) signed a collaboration and license agreement, focused on the development of novel molecules targeting neurodegenerative diseases.
Vect-Horus, Amgen, Bristol-Myers Squibb pharmaceutical-technology
December 17, 2018
Vect-Horus has signed a research agreement with Janssen Pharmaceuticals for the development of neurodegenerative disease treatments.....
Vect-Horus Announces Agreement With Johnson & Johnson Innovation pharmafocusasia
December 13, 2018
Vect-Horus announced today the signing of a research collaboration agreement with Janssen Pharmaceuticals, Inc. one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Vect-Horus and Janssen partner for neurodegenerative disease treatment SHARE pharmaceutical-technology
December 13, 2018
Vect-Horus has entered a research collaboration agreement with Johnson & Johnson subsidiary Janssen Pharmaceuticals for treating neurodegenerative diseases.....
Vect-Horus Announces Agreement With Johnson & Johnson Innovation pharmafocusasia
December 12, 2018
Vect-Horus announced today the signing of a research collaboration agreement with Janssen Pharmaceuticals, Inc. one of the Janssen Pharmaceutical Companies of Johnson & Johnson......